GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu gdk Biotechnology Co Ltd (SHSE:688670) » Definitions » Gross Profit

Jiangsu gdk Biotechnology Co (SHSE:688670) Gross Profit : ¥29.99 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Jiangsu gdk Biotechnology Co Gross Profit?

Jiangsu gdk Biotechnology Co's gross profit for the three months ended in Sep. 2024 was ¥22.87 Mil. Jiangsu gdk Biotechnology Co's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was ¥29.99 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Jiangsu gdk Biotechnology Co's gross profit for the three months ended in Sep. 2024 was ¥22.87 Mil. Jiangsu gdk Biotechnology Co's Revenue for the three months ended in Sep. 2024 was ¥35.61 Mil. Therefore, Jiangsu gdk Biotechnology Co's Gross Margin % for the quarter that ended in Sep. 2024 was 64.22%.

Jiangsu gdk Biotechnology Co had a gross margin of 64.22% for the quarter that ended in Sep. 2024 => Durable competitive advantage

During the past 7 years, the highest Gross Margin % of Jiangsu gdk Biotechnology Co was 87.49%. The lowest was 56.97%. And the median was 84.37%.


Jiangsu gdk Biotechnology Co Gross Profit Historical Data

The historical data trend for Jiangsu gdk Biotechnology Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu gdk Biotechnology Co Gross Profit Chart

Jiangsu gdk Biotechnology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial 56.66 515.43 335.09 267.90 104.73

Jiangsu gdk Biotechnology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.15 4.57 4.39 -1.83 22.87

Competitive Comparison of Jiangsu gdk Biotechnology Co's Gross Profit

For the Biotechnology subindustry, Jiangsu gdk Biotechnology Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu gdk Biotechnology Co's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangsu gdk Biotechnology Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Jiangsu gdk Biotechnology Co's Gross Profit falls into.



Jiangsu gdk Biotechnology Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Jiangsu gdk Biotechnology Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=134.591 - 29.864
=104.73

Jiangsu gdk Biotechnology Co's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=35.611 - 12.74
=22.87

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥29.99 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Jiangsu gdk Biotechnology Co's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=22.87 / 35.611
=64.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Jiangsu gdk Biotechnology Co  (SHSE:688670) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Jiangsu gdk Biotechnology Co had a gross margin of 64.22% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Jiangsu gdk Biotechnology Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Jiangsu gdk Biotechnology Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu gdk Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 12 Yujin Road, Jiangsu Province, Taizhou, CHN, 225300
Jiangsu gdk Biotechnology Co Ltd is a biological high-tech enterprise integrating scientific research, production, operation and service of human vaccines. The company's product pipeline covers prevention of five important infectious diseases such as influenza, rabies, chickenpox, shingles and pneumonia.

Jiangsu gdk Biotechnology Co Headlines

No Headlines